Kupffer cell-derived prostaglandin E2 is involved in alcohol-induced fat accumulation in rat liver

Nobuyuki Enomoto1, Kenichi Ikejima1,2, Shunhei Yamashina1, Ayako Enomoto2, Teruhiro Nishiura2, Tetsuro Nishimura2, David A. Brenner2, Peter Schemmer1, Blair U. Bradford1, Chantal A. Rivera1, Zhi Zhong1, and Ronald G. Thurman1

1 Laboratory of Hepatobiology and Toxicology, Department of Pharmacology, and 2 Division of Digestive Disease and Nutrition, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7365


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Destruction of Kupffer cells with gadolinium chloride (GdCl3) and intestinal sterilization with antibiotics diminished ethanol-induced steatosis in the enteral ethanol feeding model. However, mechanisms of ethanol-induced fatty liver remain unclear. Accordingly, the role of Kupffer cells in ethanol-induced fat accumulation was studied. Rats were given ethanol (5 g/kg body wt) intragastrically, and tissue triglycerides were measured enzymatically. Kupffer cells were isolated 0-24 h after ethanol, and PGE2 production was measured by ELISA, whereas inducible cyclooxygenase (COX-2) mRNA was detected by RT-PCR. As expected, ethanol increased liver triglycerides about threefold. This increase was blunted by antibiotics, GdCl3, the dihydropyridine-type Ca2+ channel blocker nimodipine, and the COX inhibitor indomethacin. Ethanol also increased PGE2 production by Kupffer cells about threefold. This increase was also blunted significantly by antibiotics, nimodipine, and indomethacin. Furthermore, tissue triglycerides were increased about threefold by PGE2 treatment in vivo as well as by a PGE2 EP2/EP4 receptor agonist, whereas an EP1/EP3 agonist had no effect. Moreover, permeable cAMP analogs also increased triglyceride content in the liver significantly. We conclude that PGE2 derived from Kupffer cells, which are activated by ethanol, interacts with prostanoid receptors on hepatocytes to increase cAMP, which causes triglyceride accumulation in the liver. This mechanism is one of many involved in fatty liver caused by ethanol.

fatty liver; triglyceride; adenosine 3',5'-cyclic monophosphate; ethanol


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

ALTHOUGH ALCOHOL IS A well-known hepatotoxin, the mechanisms of pathology still remain unclear. Specifically, the role of lipid accumulation remains controversial. A single large dose of ethanol in rats causes a pronounced increase in liver triglycerides that is maximal in ~24 h and disappears after 48 h (4, 20). Although fatty liver clearly occurs, whether it is a causal event in ethanol-induced hepatitis and hepatic fibrosis still remains unclear.

Interestingly, inactivation of Kupffer cells with gadolinium chloride (GdCl3) or decreasing gut-derived endotoxin by diminishing endotoxin by intestinal sterilization with antibiotics (polymyxin B and neomycin) decreased ethanol-induced steatosis in the enteral feeding model of Tsukamoto and French (1, 2). These treatments also prevented early ethanol-induced liver injury characterized by necrosis and focal inflammation. Moreover, similar phenomena were observed in rats treated with glycine, which inhibits Kupffer cells via activation of a glycine-gated chloride channel, and nimodipine, a dihydropyridine-type Ca2+ channel blocker (15-18).

Therefore, it was hypothesized that activated Kupffer cells are somehow involved in mechanisms of ethanol-induced fatty liver. Accordingly, the aim of this study was to attempt to understand if Kupffer cells are indeed involved in hepatic fat accumulation, and if so, how.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Animals and treatments. Female Sprague-Dawley rats weighing between 200 and 250 g were used in this study. All animals were given humane care in compliance with institutional guidelines. Rats were given ethanol (5 g/kg body wt po) before experiments (33, 34). Twenty-four rats were treated for 4 days with polymyxin B and neomycin (32) to prevent growth of intestinal bacteria, the main source of endotoxin in the gastrointestinal tract. On the basis of the results of preliminary experiments (2), polymyxin B (150 mg · kg-1 · day-1) and neomycin (450 mg · kg-1 · day-1) were given orally to achieve gut sterilization. Twenty-four rats were also treated with GdCl3, a selective Kupffer cell toxicant, to inactivate Kupffer cells. In this experiment, a single dose of GdCl3 (10 mg/kg) dissolved in acidic saline was administered intravenously to rats 24 h before ethanol treatment.

Analytical methods. Rats were forced to breathe into a closed heated chamber (37°C) for 20 s, and 1 ml of breath was collected using a gas-tight syringe to measure ethanol by gas chromatography. Blood ethanol concentration was assessed from breath ethanol (33, 34). Blood was collected from the portal vein in pyrogen-free heparinized syringes and centrifuged, and the plasma was stored at -20°C in pyrogen-free glass test tubes until endotoxin was measured using the Limulus amebocyte lysate assay (BioWhittaker, Walkersville, MD). Livers were formalin fixed, embedded in paraffin, and stained with hematoxylin and eosin to assess steatosis (24). Pathology was assessed in a blinded manner by one of the authors and by an independent pathologist with expertise in rodent liver.

Assay for hepatic triglycerides. To assess triglyceride content, liver tissue was homogenized in an equal volume of normal saline and extracted with a mixture of chloroform and methanol (2:1) as described previously (4, 6, 13). Zeolite was added to remove phospholipids. The resulting extract was dried under nitrogen and dissolved in Plasmanate (1 ml), and triglycerides were measured enzymatically (4-6).

Kupffer cell preparation and culture. Kupffer cells were isolated by collagenase digestion and differential centrifugation using Percoll (Pharmacia, Uppsala, Sweden) as described previously (27) with slight modifications. Briefly, the liver was perfused through the portal vein with Ca2+- and Mg2+-free Hanks' balanced salt solution (HBSS) at 37°C for 5 min at a flow rate of 26 ml/min. Subsequent perfusion was with HBSS containing 0.025% collagenase IV (Sigma Chemical, St. Louis, MO) at 37°C for 5 min. After the liver was digested, it was excised and cut into small pieces in collagenase buffer. The suspension was filtered through nylon gauze mesh, and the filtrate was centrifuged at 450 g for 10 min at 4°C. Cell pellets were resuspended in buffer, parenchymal cells were removed by centrifugation at 50 g for 3 min, and the nonparenchymal cell fraction was washed twice with buffer. Cells were centrifuged on a density cushion of Percoll at 1,000 g for 15 min, and the Kupffer cell fraction was collected and washed with buffer again. Viability of cells determined by trypan blue exclusion was >90%. Cells were seeded onto 24-well culture plates and cultured in RPMI 1640 (GIBCO Laboratories Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum and 10 mmol/l HEPES and antibiotics (100 U/ml penicillin G and 100 µg/ml streptomycin sulfate) at 37°C with 5% CO2. Nonadherent cells were removed after 15 min by replacing buffer, and cells were cultured for 4 h before experiments.

Measurement of PGE2 in conditioned media from cultured Kupffer cells. Kupffer cells isolated from rats were kept in primary culture for 4 h, and supernatants were analyzed for PGE2 by competitive RIA using 125I-labeled PGE2 from Advanced Magnetics (Cambridge, MA). Although this antibody reacts with PGE1, there is <2% cross-reactivity with other prostaglandins, arachidonic acid, and thromboxane.

RNA preparation and RT-PCR for inducible cyclooxygenase mRNA. Total RNA was prepared by guanidium/CsCl centrifugation as described previously (7, 23, 25, 26). The integrity and concentration of RNA was determined by measuring absorbance at 260 nm followed by electrophoresis on agarose gels. First-strand cDNA was transcribed from 1 µg RNA using Moloney murine leukemia virus RT (Life Technologies, Gaithersburg, MD) and an oligo(dT)16 primer (Perkin Elmer), and PCR was performed using a GeneAmp PCR system 9600 (Perkin Elmer, Foster City, CA). The primer sets used in this study are shown in Table 1 (12). We amplified 1 µl of cDNA in a 50 µl reaction buffer containing 10 pmol of forward and reverse primers, 2.5 U Taq DNA polymerase, 250 mM 2'-deoxynucleoside 5'-triphosphates (dNTPs), and 1× PCR buffer (Perkin Elmer). The reaction mixture without enzyme and dNTPs was heated at 100°C for 4 min, then a mixture of Taq polymerase and dNTP was added at 80°C. Thereafter, 40 cycles of denaturing at 94°C for 60 s, annealing at 50°C for 90 s, and extension at 72°C for 120 s followed by final extension at 72°C for 10 min were carried out. The size of the PCR products was verified by electrophoresis in 2% agarose gels followed by ethidium bromide staining. Densitometric analysis using NIH image software was performed for semiquantification of PCR products.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Primer sequences used for PCR

Tissue extraction. One part of the liver was homogenized with 9 parts 10% TCA using a Polytron homogenizer. The supernatant was centrifuged with 5 vol of water-saturated ether. The ether layer then was removed, and extraction of the aqueous layer was repeated two times. Residual ether was removed from the aqueous layer.

Measurement of cAMP. Intracellular cAMP was measured in suspensions of parenchymal cells by RIA using 125I-labeled-cAMP from Biomedical Technologies (31). Parenchymal cells were incubated in RPMI 1640 medium containing various concentrations of PGE2 at 37°C. For some experiments, 0.5 mM IBMX was preincubated with parenchymal cells for 2 min before the addition of PGE2. After 5 min, cells were washed with cold PBS, centrifuged in polypropylene tubes, and treated with 0.05 M HCl. Tubes were then placed in boiling water for 3 min. Standards and unknowns were combined with tracer solution and antibody and were incubated 18-20 h at 4°C. Acetate buffer (1 ml) was added, the tubes were centrifuged, and the pellets were separated from the supernatant. Radioactivity in the precipitate was counted and compared with known values from a standard curve.

Statistical analysis. All results were expressed as means ± SE. Statistical differences between means were determined using ANOVA or ANOVA on ranks as appropriate. P < 0.05 was selected before the study to reflect significance.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of antibiotics. After oral administration of ethanol (5 g/kg) to untreated normal rats, blood ethanol levels increased gradually and reached ~250 mg/dl after 90 min (Table 2). Similar results were obtained in rats treated with antibiotics. Plasma endotoxin levels in the portal vein were increased about fourfold to ~90 pg/ml 1.5 h after ethanol (Table 2). This effect was blocked by antibiotics.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effect of acute ethanol and antibiotics on blood alcohol and endotoxin levels

Effect of drugs affecting Kupffer cells on hepatic triglyceride levels and liver histology. Liver weight was measured before experiments, and no significant differences between the groups studied were detected (data not shown). Liver specimens were collected for histology 24 h after administration of ethanol (5g/kg po). Histology was normal in control rats (Fig. 1A), whereas ethanol caused steatosis in the liver as expected (Fig. 1B). Histological changes were blunted almost completely by intestinal sterilization with antibiotics, inactivation of Kupffer cells with GdCl3, inhibition of intracellular Ca2+ concentration influx with the Ca2+ channel blocker nimodipine, and the cyclooxygenase (COX) inhibitor indomethacin (Fig. 1, C-F).


View larger version (142K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of drugs affecting Kupffer cells on changes in liver histology due to ethanol. Photomicrographs (hematoxylin and eosin) are of livers from rats treated as described in MATERIALS AND METHODS. Nimodipine, a dihydropyridine-type Ca2+ channel blocker, was given to prevent the increase in intracellular Ca2+ concentration in Kupffer cells after lipopolysaccharide (LPS) addition (16). A single dose of nimodipine (1 mg/kg ip) was administered 1 h before ethanol. Indomethacin, a cyclooxygenase (COX) inhibitor, prevented PGE2 production in Kupffer cells after LPS stimulation. On the basis of the results from preliminary experiments, indomethacin (3 mg · kg-1 · day-1) was given daily 7 days before ethanol treatment. A: no treatment; B: 24 h after ethanol (5 g/kg po); C: antibiotics for 4 days and ethanol for 24 h; D: gadolinium chloride (GdCl3) for 24 h and ethanol for 24 h; E: nimodipine for 1 h and ethanol for 24 h; F: indomethacin (3.6 mg · kg-1 · day-1) for 7 days and ethanol for 24 h (original magnification, ×400); n = 4 typical photomicrographs.

Mean liver triglycerides in vehicle-treated controls were 5.5 ± 1.0 mg/g liver (Fig. 2), and values were increased about threefold by ethanol as expected. This increase was prevented nearly completely by prior treatment of rats with antibiotics, GdCl3, nimodipine, or indomethacin.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of drugs affecting Kupffer cells on hepatic triglyceride levels. Rats were treated with ethanol as described in MATERIALS AND METHODS. Hepatic triglycerides were extracted and measured enzymatically. Results are means ± SE; n = 4. * P < 0.05 vs. control; # P < 0.05 vs. ethanol by ANOVA and Bonferroni's post hoc test.

PGE2 production by conditioned media from Kupffer cells treated with ethanol. PGE2 production by Kupffer cells from untreated control rats was 43 ± 5 pmol · 106 cells-1 · 4 h-1 (Fig. 3). Ethanol treatment increased values about threefold. This increase was also blunted significantly by antibiotics, nimodipine, or indomethacin.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of drugs affecting Kupffer cells on PGE2 production by conditioned media from Kupffer cells. Rats were treated with ethanol and drugs affecting Kupffer cells as described in MATERIALS AND METHODS and the Fig. 1 legend. PGE2 production by conditioned media from Kupffer cells was measured by ELISA. Results are means ± SE; n = 4. * P < 0.05 vs. control; # P < 0.05 vs. ethanol by ANOVA and Bonferroni's post hoc test.

Effect of PGE2, ethanol, and cAMP analogs on tissue triglycerides. Liver specimens were collected for histology and measurement of tissue triglycerides 24 h after injection of PGE2 (1 mg/kg iv). Tissue triglycerides were elevated nearly twofold by PGE2 or ethanol treatment (Fig. 4). Interestingly, ethanol and PGE2 were additive under these conditions.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of PGE2 on hepatic triglyceride content. Rats were given prostaglandin E2 (1 mg/kg, iv) 24 h before ethanol. Hepatic triglycerides were extracted and measured enzymatically as described in MATERIALS AND METHODS. Results are means ± SE; n = 4. * P < 0.05 vs. control; # P < 0.05 vs. PGE2 by ANOVA and Bonferroni's post hoc test.

Analogs of PGE2, 17-phenyl-omega-trinor-PGE2 (17-PGE2, an EP1/EP3 agonist) or 11-deoxy PGE1 (11-PGE1, an EP2/EP4 agonist), were injected (1 mg/kg iv) 24 h before tissue triglyceride measurements. Cell permeable cAMP analogs were also examined for their effect on tissue triglycerides. Dibutyryl cAMP (DBcAMP; 1 mg/kg) and 8-bromoadenosine cAMP (8-BrcAMP; 1 mg/kg) were injected intravenously 8 h before tissue triglyceride measurements. The level of cAMP in the liver was increased significantly by these treatments (Table 3). Moreover, tissue triglycerides were elevated about threefold by an EP2/EP4 agonist, but an EP1/EP3 agonist had no effect (Fig. 5). CAMP analogs also increased triglycerides two- to threefold.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Effect of cAMP analogs on liver levels of cAMP



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of PGE2 and cAMP analogs on hepatic triglyceride content. Agonists of PGE2, 17-phenyl-omega-trinor-PGE2 (17-PGE2, an EP1/EP3 agonist), or 11-deoxy PGE1 (11-PGE1, an EP2/EP4 agonist), were injected (1 mg/kg iv) 24 h before tissue triglyceride measurements. Cell permeable cAMP analogs were also examined for their effect in triglycerides. Dibutyryl-cAMP (DBcAMP; 1 mg/kg) and 8-bromoadenosine cAMP (8-BrcAMP; 1 mg/kg) were injected intravenously for 8 h before tissue triglyceride measurements. Hepatic triglycerides were extracted and measured enzymatically as described in MATERIALS AND METHODS. Results are means ± SE; n = 4. * P < 0.05 vs. control by ANOVA and Bonferroni's post hoc test.

Effect of drugs affecting Kupffer cells on expression of inducible COX mRNA from rat liver treated with ethanol. Inducible COX (COX-2) mRNA expression was undetectable in livers from untreated control rats but was detected within 90 min after lipopolysaccharide (LPS; 1 mg/kg). Moreover, COX-2 mRNA expression was increased by treatment with ethanol (2 h) nearly as much as with LPS (Fig. 6). This increase was blocked totally by antibiotics, GdCl3, nimodipine, and indomethacin.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 6.   RT-PCR analysis of inducible COX (COX-2) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. A: total liver RNA isolated 2 h after ethanol (5 g/kg) administration was used to detect COX-2 mRNA. GAPDH was also detected as a housekeeping gene and phi X174/Hae III was used to determine the size of PCR products. Lane 1, LPS-treated positive control; lane 2, untreated control; lane 3, ethanol; lane 4, antibiotics + ethanol; lane 5, GdCl3 + ethanol; lane 6, nimodipine + ethanol; lane 7, indomethacin + ethanol; lane 8, no RNA. Gel is representative of 4 individual experiments. MW, molecular weight. B: results are means ± SE; n = 4. * P < 0.05 vs. control. # P < 0.05 vs. ethanol by ANOVA and Bonferroni's post hoc test.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Kupffer cells And endotoxin are involved in mechanisms of fatty liver. Many physiological factors participate in ethanol-induced fatty liver (22). For example, fatty acid synthesis increases, fatty acid oxidation decreases, release of lipoproteins diminishes, and systemic adrenergic activity increases cause peripheral lipolysis. With this study, a role for Kupffer cells can be added to this list. One possible explanation for the results observed here is as follows. A single large dose of ethanol increases gut-derived endotoxin in the circulation (Table 2). Endotoxin is removed from the circulation primarily by Kupffer cells, which are activated leading to rapid increases in intracellular Ca2+, which in turn activates phospholipase A2. This increases PGE2 synthesis via mechanisms involving COX-2 (21) (Fig. 6). PGE2 then acts on receptors on hepatocytes to increase triglycerides in the liver (Fig. 7). Previous studies (1, 2) showed that inactivation of Kupffer cells with GdCl3 and intestinal sterilization with antibiotics (polymyxin B and neomycin) prevented alcohol-induced steatosis in the enteral feeding model of Tsukamoto and French. However, how the Kupffer cell is involved in mechanisms of hepatic triglyceride accumulation remains unclear. Here, one single large dose of ethanol also increased neutral lipid in the liver (4, 20) (Figs. 1 and 2). Moreover, in this study, inactivation of Kupffer cells with GdCl3, intestinal sterilization with antibiotics, prevention of influx of extracellular Ca2+ with a Ca2+ channel blocker, and inhibition of COX all reduced hepatic lipid accumulation (Figs. 1 and 2). Accordingly, it is concluded that Kupffer cells and endotoxin are involved in mechanisms of fatty liver.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 7.   Working hypothesis depicting one mechanism by which alcohol causes hepatic steatosis via mechanisms dependent on endotoxin and Kupffer cells. One large dose of ethanol increases gut-derived endotoxin in the circulation. Endotoxin is removed from the circulation primarily by Kupffer cells, which are activated leading to rapid increases in intracellular Ca2+, which in turn activates phospholipase A2 (PLA2). This increases PGE2 synthesis via mechanisms involving COX-2. PGE2 then acts on receptors on hepatocytes to increase triglyceride accumulation via mechanisms involving cAMP. This presents only one mechanism involved in fatty liver caused by ethanol. VDCC, voltage-dependent Ca2+ channel, AA, arachidonic acid, AC, adenylate cyclase; Gp, G protein, alpha GP, alpha -glycerophosphate, TG, triglyceride.

PGE2 is involved in triglyceride accumulation in hepatocytes. Eicosanoids are bioactive lipids produced in large quantities by macrophages from arachidonic acid that is released from membrane lipids through the action of phospholipase A2 (3, 9). Arachidonic acid produced via the COX pathway leads to the formation of prostaglandins, key mediators of cell signaling between Kupffer cells and hepatocytes (28). PGE2 production from Kupffer cells was enhanced by ethanol, a phenomenon blunted by antibiotics, nimodipine, and indomethacin (Fig. 3). Triglyceride accumulation was also increased by PGE2, and this effect was enhanced by the addition of ethanol (Fig. 4). Many of the known biological effects of PGE2 are mediated through interaction of PGE2 with specific receptors (8, 14), and at least four subtypes (EP1, EP2, EP3, and EP4) have been characterized pharmacologically and cloned from at least one species (8, 19). The specific receptor subtypes are known to be coupled to different signal transduction pathways. EP1 receptors are coupled to inositol phospholipid turnover, resulting in an increase of intracellular Ca2+ concentration. EP2/EP4 receptors act via Gs proteins and increase cAMP, whereas EP3 receptors are coupled to Gi and decrease cAMP (28). In this study, 11-deoxy PGE1, an EP2/EP4 agonist, enhanced triglyceride production, whereas 17-PGE2, an EP1/EP3 agonist, had no effect on tissue triglyceride levels (Fig. 5). Moreover, cAMP increased triglyceride accumulation (Fig. 5). Accordingly, it is concluded that Kupffer cell-derived PGE2 is involved in triglyceride accumulation in hepatocytes via mechanisms dependent on hepatocyte EP2/EP4 receptors and cAMP. Indeed, it has been reported that ethanol increases cAMP, and it is well known that PGE2 increases cAMP (20).

PGE2 is regulated by COX-2. PGE2 is synthesized in Kupffer cells via the COX pathway (29, 30), and the COX-2 gene may play an important role in liver injury. Dinchuk et al. (10) showed that COX-2 mediates endotoxin-induced liver injury in experiments with COX-2-deficient mice. On the other hand, indomethacin, a nonspecific COX inhibitor, prevented histological changes in the liver and PGE2 production from Kupffer cells caused by gut-derived endotoxin (Figs. 1-3). Recently, Nanji et al. (25) showed that upregulation of COX-2 in chronic alcoholic liver injury increased synthesis of inflammatory and vasoactive eicosanoids. Furthermore, Nanji et al. (26) showed that dietary saturated fatty acids suppressed COX-2 expression in alcohol-induced liver injury. In this study, COX-2 mRNA expression was increased by treatment with ethanol in only 2 h (Fig. 6). This expression was totally blocked by treatment with antibiotics (Fig. 6). Therefore, these data support the hypothesis that endotoxin-induced increases in COX-2 expression increase PGE2 production.

In summary, one large dose of ethanol is sufficient to increase gut-derived endotoxin in the circulation. Endotoxin is removed primarily by Kupffer cells that are activated, leading to rapid increases in COX-2 and intracellular Ca2+, the latter of which in turn activates phospholipase A2. This increases PGE2, which acts on receptors in hepatocytes to increase accumulation of triglycerides. This pathway is one of many physiological processes involved in mechanisms of fatty liver caused by ethanol (Fig. 7).


    ACKNOWLEDGEMENTS

This study was supported in part by grants from the National Institute on Alcohol Abuse and Alcoholism.


    FOOTNOTES

Portions of this work have been presented previously in abstract form (see Ref. 11).

Address for reprint requests and other correspondence: Blair U. Bradford, Laboratory of Hepatobiology and Toxicology, Dept. of Pharmacology, CB#7365, Mary Ellen Jones Bldg, Univ. of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7365 (E-mail: beub{at}med.unc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Received 26 April 1999; accepted in final form 9 March 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Adachi, Y, Bradford BU, Gao W, Bojes HK, and Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20: 453-460, 1994[ISI][Medline].

2.   Adachi, Y, Moore LE, Bradford BU, Gao W, and Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108: 218-224, 1995[ISI][Medline].

3.   Birmelin, M, and Decker K. Ca2+ flux as an initial event in phagocytosis by rat Kupffer cells. Eur J Biochem 131: 539-543, 1983[Abstract].

4.   Brodie, BB, Butler WM, Horning MG, Maickel RP, and Maling HM. Alcohol-induced triglyceride deposition in liver through derangement of fat transport. Am J Clin Nutr 9: 432-435, 1961[ISI].

5.   Bucolo, G, and David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19: 476-482, 1973[Abstract/Free Full Text].

6.   Butler, WM, Maling HM, Horning MG, and Brodie BB. The direct determination of liver triglycerides. J Lipid Res 2: 95-96, 1961[Free Full Text].

7.   Chirgwin, JM, Przybyla AE, MacDonald RJ, and Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979[ISI][Medline].

8.   Coleman, RA, Kennedy I, Humphrey PPA, Bunce K, and Lumley P. Prostanoids and their receptors. In: Comprehensive Medicinal Chemistry, edited by Hansch C, Sammes PG, Taylor JB, and Emmett JC.. Oxford: Pergamon, 1989, p. 643-714.

9.   Decker, K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192: 245-261, 1990[ISI][Medline].

10.   Dinchuk, JE, Car BD, Focht RJ, Johnston JF, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, and Trzaskos JM. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409, 1995[ISI][Medline].

11.   Enomoto, N, Ikejima K, Bradford BU, Rivera CA, Arteel GE, Zhong Z, and Thurman RG. Kupffer cell-derived prostaglandin E2 is involved in alcohol-induced fatty liver (Abstract). Gastroenterology 114: 1238, 1998.

12.   Feng, L, Sun W, Xia Y, Tang W, Chanmugan X, Sayoola E, Wilson C, and Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 307: 361-368, 1993[ISI][Medline].

13.   Folch, J, Lees M, and Stone-Stanley GH. A simple method for the isolation and purification of total lipid from animal tissue. J Biol Chem 226: 497-509, 1957[Free Full Text].

14.   Funk, C, Furci L, Fitzgerald GA, Grygorczyk R, Rochette C, Bayne MA, Abramovitz M, Adam M, and Metters MK. Cloning and expression of a cDNA for human prostaglandin E receptor EP1 subtype. J Biol Chem 268: 26767-26772, 1993[Abstract/Free Full Text].

15.   Iimuro, Y, Bradford BU, Forman DT, and Thurman RG. Glycine prevents alcohol-induced liver injury by decreasing alcohol in the stomach. Gastroenterology 110: 1536-1542, 1996[ISI][Medline].

16.   Iimuro, Y, Ikejima K, Rose ML, Bradford BU, and Thurman RG. Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis due to chronic intragastric ethanol exposure in the rat. Hepatology 24: 391-397, 1996[ISI][Medline].

17.   Ikejima, K, Iimuro Y, Forman DT, and Thurman RG. A diet containing glycine improves survival in endotoxin shock in the rat. Am J Physiol Gastrointest Liver Physiol 271: G97-G103, 1996[Abstract/Free Full Text].

18.   Ikejima, K, Qu W, Stachlewitz RF, and Thurman RG. Kupffer cells contain a glycine-gated chloride channel. Am J Physiol Gastrointest Liver Physiol 272: G1581-G1586, 1997[Abstract/Free Full Text].

19.   Inomoto, YN, Ding M, Nakata H, Narumiya S, Sugimoto Y, Honda A, Ichikawa A, Chiba T, and Kinoshita Y. Copresence of prostaglandin EP2 and EP3 receptors on gastric enterochromaffin-like cell carcinoid in African rodents. Gastroenterology 109: 341-347, 1995[ISI][Medline].

20.   Jauhonen, VP, Savolainen MJ, and Hassinen IE. Cyclic AMP-linked mechanisms in ethanol-induced derangements of metabolism in rat liver and adipose tissue. Biochem Pharmacol 24: 1879-1883, 1975[ISI][Medline].

21.   Kawada, N, Mizoguchi Y, Kobayashi K, Monna T, and Morisawa S. Calcium-dependent prostaglandin biosynthesis by lipopolysaccharide-stimulated rat Kupffer cells. Prostaglandins Leukot Essent Fatty Acids 47: 209-214, 1992[ISI][Medline].

22.   Lieber, CS, and Savolainen M. Ethanol and lipids. Alcohol Clin Exp Res 8: 409-423, 1984[ISI][Medline].

23.   Nanji, AA, Khwaja S, Rahemtulla A, Miao L, Zhao S, and Tahan SR. Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat. Gastroenterology 112: 200-207, 1997[ISI][Medline].

24.   Nanji, AA, Mendenhall CL, and French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 13: 15-19, 1989[ISI][Medline].

25.   Nanji, AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR, and Dannenberg AJ. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 112: 943-951, 1997[ISI][Medline].

26.   Nanji, AA, Rahemtulla A, Daly T, Khwaja S, Miao L, Zhao S, and Tahan SR. Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the rat. Hepatology 26: 90-97, 1997[ISI][Medline].

27.   Pertoft, H, and Smedsrod B. Separation and characterization of liver cells. In: Cell Separation: Methods and Selected Applications, edited by Pretlow TG II, and Pretlow TP.. New York: Academic, 1987, vol. 4, p. 1-24.

28.   Puschel, GP, Kirchner C, Schroder A, and Jungermann K. Glycogenolytic and antiglycogenolytic prostaglandin E2 actions in rat hepatocytes are mediated via different signaling pathways. Eur J Biochem 218: 1083-1089, 1993[Abstract].

29.   Qu, W, Savier E, and Thurman RG. Stimulation of monooxygenation and conjugation following liver transplantation in the rat: involvement of Kupffer cells. Mol Pharmacol 41: 1149-1154, 1992[Abstract].

30.   Qu, W, Zhong Z, Goto M, and Thurman RG. Kupffer cell prostaglandin E2 stimulates parenchymal cell O2 consumption: alcohol and cell-cell communication. Am J Physiol Gastrointest Liver Physiol 270: G574-G580, 1996[Abstract/Free Full Text].

31.   Regan, JW, Bailey TJ, Pepperl DJ, Pierce KL, Bogardus AM, Donello JE, Fairbairn CE, Kedzie KM, Woodward DF, and Gil DW. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol Pharmacol 46: 213-220, 1994[Abstract].

32.   Sato, H, Guth PH, and Gossman MI. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology 84: 483-489, 1983[ISI][Medline].

33.   Thurman, RG, Paschal DL, Abu-Murad C, Pekkanen L, Bradford BU, Bullock KA, and Glassman EB. Swift increase in alcohol metabolism (SIAM) in the mouse: Comparison of the effect of short-term ethanol treatment on ethanol elimination in four inbred strains. J Pharmacol Exp Ther 223: 45-52, 1982[Abstract].

34.   Wendell, GD, and Thurman RG. Effect of ethanol concentration on rates of ethanol elimination in normal and alcohol-treated rats in vivo. Biochem Pharmacol 28: 273-279, 1979[ISI][Medline].


Am J Physiol Gastrointest Liver Physiol 279(1):G100-G106
0193-1857/00 $5.00 Copyright © 2000 the American Physiological Society